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A live dog is better than a dead lion
Richard M. Green, MD, New York, NYI am honored to stand before you as the 58th president
of the Society for Vascular Surgery (SVS). I do so with a
sense of gratitude and pride. I wish to thank and acknowl-
edge each of you who worked so hard to energize our
society. We have moved to Chicago, and our national
headquarters is fully operational. The already obvious effi-
ciencies validate the merger and the move. The seamless,
yet rapid, transition is testimony to Becky Maron’s effec-
tiveness as our Executive Director.
A GLIMPSE OF REALITY IN 2004
We are a special group, perhaps the ultimate multi-
taskers. Imagine the skill set of a single individual able to
repair a thoracoabdominal aneurysm, recanalize an oc-
cluded superficial femoral artery percutaneously, and treat a
deep venous thrombosis, all in the same day. All of these
skills are reflected in this exciting program in which inves-
tigators from all over the world are gathered to exchange
information. But something is wrong. The enthusiasm at
this meeting is created in a too small number of programs,
and we are having trouble selling our message.
The unfilled positions in the vascular match are shown
in Fig 1. For the 10 years between 1992 and 2002, some-
where between 0 and 6 positions were unmatched annually.
This year 23 positions were unmatched. While the overall
number of positions has increased, the applicant pool has
decreased in quantity and quality. In 1995 72 positions
were offered in 62 programs, and 95 of the 110 applicants
were graduates of US medical schools. This last year 110
positions were offered in 90 programs, and 82 of the 112
applicants were graduates of US medical schools (National
Resident Matching Program data, available at: www.nrmp.
org). The trends are ominous.
When things go poorly there must be villains. Let’s not
blame other specialties, the length of our training, Gener-
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school. Let’s put the blame where it belongs; blame our
content.
My perspective comes from 3 distinct experiences, as an
officer of SVS, as a former program director, and as a practic-
ing vascular surgeon. My heritage is the vascular room at
Strong Memorial Hospital, with Drs Charles Rob and Jim
DeWeese as my mentors. I recently left these comfortable
confines, with its deep tradition of vascular surgery excellence,
to accept the challenge of building a vascular institute at
Lenox Hill Hospital, an institution with an equally deep
tradition of cardiology dominance. With that pedigree I be-
lieve I can speak credibly about the world we live in.
My theme comes from the book of Ecclesiastes. Attrib-
uted to King Solomon, it was directed at the ancient
Judeans who were looking to survive in a world dominated
by Greek rule. The Judeans had lost their sense of opti-
mism, and Solomon recognized that there were but two
options: act in the face of adversity or fade away. Ecclesi-
astes 2:24, “A live dog is better than a dead lion,” has as
much relevance for contemporary vascular surgeons as it
did for those ancient Judeans.
We must resolve 2 critical problems related to content.
The first is our status as a sub-specialty of general surgery,
and the second is the anticipated introduction of carotid
stenting into clinical practice. Sub-specialty status affects
the content of what we teach and therefore our ability to
recruit and properly train a workforce capable of providing
care at a level consistent with our heritage. The clinical
launch of carotid stenting affects the content of what we do,
and introduces a treatment option unfamiliar and unavail-
able to most vascular surgeons in one of our defining areas.
Even worse, we face a crisis over our legitimacy as vascular
care providers, and, sadly, our ability to effect meaningful
change is limited.
The founding members of SVS were the ancient Greeks
of surgery, those high political powers with academic,
medical, and social influence. They were free to innovate at
their own leisurely pace, and the only scrutiny on their
activities was self-imposed. They came from New Orleans,
Harvard, and Johns Hopkins. It was their preeminence that
drew many of us into the field. They succeeded because
they were innovative, daring, and good. Norman Hertzer
was absolutely correct in his SVS presidential address in583
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a little more than 50 years, despite our good results we have
become more like the Judeans than our Greek ancestors, a
distinct minority in a world where we were once masters.
Recent industry estimates indicate that less than 15% of the
7000 physicians who perform percutaneous vascular inter-
ventions in the United States are vascular surgeons.
Minority status is not just a function of numbers,
however; it is also a reflection of society, and ours readily
accepts new technologies, not because of their superiority,
but because something in the balance of risk, cost, and
performance meets a social or consumer need. Those of you
experiencing minority status for the first time may find it
uncomfortable. You are not used to scrutiny from out-
siders, and react poorly and defensively when what you do
is challenged.
THE CRISIS OF CONTENT: WHAT WE TEACH
My support for an independent board of vascular sur-
gery was always predicated on a need to radically change the
way we train our fellows. While I understand that there are
other issues, boards are responsible for training and certifi-
cation. Until now, the only mechanism possible under the
American Board of Medical Specialties rules to expand
vascular education and reduce the nonessential elements of
general surgery was an independent board for vascular
surgery. What is the likelihood that a small group such as
ours can succeed in this quest? A steel-willed central au-
thority holds the advantage against any uprising.
To preserve its rights it is sometimes necessary for a
minority to confront power. Dr Martin Luther King, in
response to critics of his tactics, wrote the following from a
jail cell in Birmingham, Alabama, in 1963:
Non-violent direct action seeks to create such a crisis and
establish such creative tension that a community that has
constantly refused to negotiate is forced to confront the
issue. It seeks to dramatize the issue so that it can no
longer be ignored. . .we have not made a single gain in
civil rights without determined legal and nonviolent pres-
Fig 1. Unfilled positsure. History is a long and tragic story of the fact that
privileged groups seldom give up their privileges
voluntarily. . . .2
Our “creative tension” was orchestrated through the
activities of the American Board of Vascular Surgery
(ABVS) with the support of this society. Vascular surgery
tried to secure its rightful place when in 1996 our leader-
ship decided to establish a Primary Specialty Board of
Vascular Surgery. The decision to move in this direction
was supported by the vast majority of vascular surgeons in
the United States. While a number of positive American
Board of Surgery (ABS) actions dealt with symptoms of our
past concerns, none addressed the fundamental issues re-
garding flexibility in our training programs. Serious at-
tempts at resolving these more difficult matters by several of
my predecessors, notably, Drs Hobson and Berguer, were
rebuffed in less than gracious style. While the arguments for
independence were compelling, the outcome was not sur-
prising when viewed in the context of minority group
survival.The number 1 priority of the September 2003 SVS
Critical Initiatives Retreat was to reopen communications
with the ABS to determine whether progress might be
made with regard to a radical change in the vascular surgical
training paradigms. Although there was reaffirmation of
support for the ABVS, there was pessimism that a timely
solution could be achieved. Dr Jack Cronenwett and I met
with Drs Frank Lewis and Ron Meier during the American
College of Surgeons meeting in Chicago last October,
along with Drs Frank Logerfo and John Ricotta represent-
ing the Vascular Surgery Board. At that meeting we were
told that the ABS would consider moving vascular surgery
to primary certification status if a change in training was
indeed our primary goal. As a consequence, the design and
control of vascular surgical training would be at the discre-
tion of vascular surgeons, and general surgical certification
would no longer be required for those who limit their
practice to vascular surgery. As a sign of good faith, Dr
Lewis requested that I ask the ABVS to defer its appeal of
the adverse Liaison Committee for Specialty Boards deci-
n the vascular match.ions i
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where there was unanimous support for moving forward.
In addition, the ABVS agreed to defer its appeal.Later on in
the fall an expanded and representative group of vascular
educators met in New York City to discuss the initiative.
There was consensus for a proposal to make vascular train-
ing similar to plastic surgical training, with a variety of
options including one with dual certification and one with
single certification beginning directly after medical school.
A final meeting was held in Philadelphia, with Jim Stanley
representing the ABVS and Barbara Bass representing the
ABS, in which the outline of the proposal that would be
presented to the ABS directors in January was discussed. A
subsequent meeting of ABVS directors that evening de-
cided not to support the primary certificate, but the SVS
Executive Committee agreed to proceed.The proposal ne-
gotiated with the ABS to move vascular surgery to primary
certificate designation was unanimously approved by the
ABS directors. An application was written jointly by repre-
sentatives of the ABS and SVS, and was submitted to the
American Board of Medical Specialties in March 2004.
Approval is anticipated in March 2005. A paragraph from
the preamble summarizes the effort:
[T]o. . .move to a paradigm in which vascular surgery
training is independent of general surgical training re-
quires that the vascular surgery certificate move from
subspecialty to primary status. This is the purpose of this
application. It is anticipated that the transition in training
will be gradual, and dual training pathways will be main-
tained for the foreseeable future, such that existing ap-
proved pathways will continue for those seeking certifica-
tion in both general surgery and vascular surgery while
new training pathways for those seeking training only in
vascular surgery will be created. A model similar to that
currently in place for plastic surgery is envisioned, such
that medical school graduates may match directly into
vascular surgery residencies, or may choose to complete
general surgical training before entering vascular sur-
gery.3
The efforts of the ABVS, although sometimes more
aggressive than some might like, provided the impetus that
in large part moved the ABS, at last, to confront the issue of
primary certification for vascular surgery. This did not
occur in a vacuum, however, because a group that I referred
to in 1997 as “arrogant and out of touch, non-reactive to
changing realities,”4 is younger, more specialized and try-
ing to accommodate change in the entirety of surgery. I
have absolutely no reservations about the sincerity of the
ABS directors at this time, and their desire to give vascular
surgery the independence necessary while remaining a part-
ner in those areas of mutual interest.
We have achieved in the recent negotiations almost
everything we asked for. I know that there are unresolved
issues, in particular surrounding the construct of the Resi-
dency Review Committee, and those will be dealt with as
the process evolves. It is now time to accept this victory, torecognize the accomplishments of Drs Ramon Berguer,
Bob Hobson, Jim Stanley, Frank Veith, and many others
(and that list is in alphabetic order), whose vision and
perseverance have brought us to this threshold, and to
move quickly to full implementation of our own primary
certificate. And I emphasize the word quickly, or an antic-
ipated void will be filled by those specialties able to provide
a competent workforce.
To those who say that this is at best a temporary solution,
and at worst a classic Faustian bargain, I say, you may be right,
but it is a risk we must take. In my opinion, the ABS has gone
as far as it can go at this time, and our ultimate relationship
will not be determined by further political pressure, but by
evolution of our specialty. If we continue to perform intra-
abdominal procedures, this solution will work and may
actually be preferable to a stand-alone scenario, because we
will have assurance that our trainees will get preferential
rotations in general surgery. If the balance continues to
shift in the direction of the angiography suite, our relation-
ship will be of historic interest only. We have not reached
that point, although I believe that we will.
To those who believe this is not what we set out to
achieve, I disagree. Internal conflict represents the abyss of
any minority condition; at best it is a nuisance, at worst it is
fatal. To the extent that we encumber our young with our
old battles, we fail. This has become an old battle. A live
dog, vascular surgery that designs and controls the content
of its training programs, is better than a dying specialty,
once king of the jungle but now unable to replenish its food
chain.
THE CRISIS OF CONTENT: WHAT WE DO
Our second critical challenge is to involve vascular
surgeons in carotid stenting. This is all about the content of
what we do. The segue to percutaneous therapy for a
condition that once defined our specialty is a painful but
necessary one for us if we are to maintain our legitimacy,
and there is no better way to claim legitimacy than to
demonstrate competence. On the eve of the clinical launch
of carotid stenting there are an insufficient number of
vascular surgeons who can make that claim.
It became very clear to me several years ago that our
participation in carotid stenting programs on a grand scale
would be contingent on our public acceptance of the
procedure for limited indications. We were appropriately
considered hypocritical when some vascular surgeons with
percutaneous expertise asked industry for access to devices
and our official position remained unsupportive. How
could we ask to be trained in private for a procedure we
criticized in public? We could not, and have any credibility.
We chose not only to support a Current Procedural
Terminology code and a request to remove the national
non-coverage policy, but we offered Dr Robert Zwolak,
unquestionably one of the most effective physicians in the
area of government activity, regardless of specialty, to write
the proposals. More recently we spoke on behalf of ap-
proval for the Precise Stent/AngioGuard Cerebral Protec-
tion System (Cordis Endovascular) at the recent Food and
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may not be able to preserve carotid endarterectomy on a
pre-2004 scale, we have ensured the opportunity for vascu-
lar surgeons with percutaneous expertise to treat carotid
bifurcation stenosis. Once again we chose the live dog over
the dead lion, but this battle is not over.
Vascular surgeons may well possess the skill, the knowl-
edge, and the patient volume to perform carotid stenting,
but they must also have credentials. The elements of carotid
stenting are listed in the Table. The endocompetent vascu-
lar surgeon has all the requisite skills, and should only
require training for using the embolic filter device. It is
unfortunate that there is no consensus on the fundamental
question as to who is qualified to perform carotid stenting.
The ability to provide periprocedural care and knowledge
about the risk factors for atherosclerosis are matters of great
importance, and should be at the top of the list. I am
amazed that anyone is paying serious attention to the
totally wrong but well-formulated radiology position that
states that the essence of this procedure is experience with a
dangerous diagnostic procedure and dismisses any other
interventional experience as irrelevant.5 The radiologists
have carefully analyzed the risk factors for cerebral angiog-
raphy, and without question have shown that this is a
dangerous procedure and that practice makes one a better
angiographer.6 We recognized this a long time ago, and
have abandoned it as routine before carotid endarterec-
tomy.
At Lenox Hill Hospital, with experience approaching
1000 carotid stenting procedures, we see no need for
routine arch and 4-vessel diagnostic angiography, and use
duplex scanning, magnetic resonance angiography, and
single-vessel angiography. These methods provide suffi-
Essential elements of the carotid stenting procedure*
Element
Vascular
surgeon
Endo-
competent
vascular
surgeon
Clinical evaluation of patient Yes Yes
Initial diagnostic angiographic evaluation Yes Yes
Benefit/risk assessment Yes Yes
Device selection No Yes
Accessing common carotid with sheath No Yes
Selection of antithrombin therapy Yes Yes
Positioning embolic protection device No No
Pre-dilatation of lesion No Yes
Hemodynamic assessment and management Yes Yes
Stent deployment No Yes
Post-dilatation No Yes
Retrieval of embolic protection device No Yes
Final angiographic evaluation Yes Yes
Sheath removal (vascular closure device) No Yes
Clinical, hemodynamic, and neurologic
assessment and management
No Yes
Post-procedure management, follow-up,
and care
Yes Yes
*An endocompetent vascular surgeon has all the requisite skills, and should
only require training in use of the specific embolic filter protection device.cient information that the performance of efficacious ca-
rotid stenting, with embolic filter devices, may be under-
taken without the unnecessary trauma to the aortic arch
and its branches from repetitive catheter manipulations.
Any attempt to mandate a fixed number of unnecessary and
dangerous diagnostic tests to learn a procedure that is
intended to reduce the incidence of stroke will have the
exact opposite effect, regardless of the specialty of the
trainee.
While vascular surgery has been supportive of Food and
Drug Administration and Centers for Medicare and Med-
icaid Services approval of carotid stenting, we have done so
with certain provisos.7 We believe that the inclusion criteria
should be divided into anatomic and medical criteria. An-
atomic criteria would include patients with significant ca-
rotid stenosis and contralateral carotid occlusion, contralat-
eral laryngeal nerve palsy, radiation therapy to the neck, or
previous carotid endarterectomy with recurrent stenosis.
The medical criteria are more difficult to define, because
the degree of risk from carotid endarterectomy is signifi-
cantly affected by the team performing the operation. Vari-
able institutional results should affect patient selection for
stenting. Collaboration between the interventionalist and
the surgeon who performs carotid endarterectomy, unless
it is the same person, must occur to reach institutional
consensus on high risk.
In the attempt to obtain credentials we must never lose
sight of the quality of care that we have always been
associated with. It is what has distinguished us from others
performing vascular procedures, and we cannot let patient
safety suffer. This means that we need to consider seriously
what credentialing document we put forward. It needs to
be responsible, it needs to be realistic, and it may mean, for
a time, that some vascular surgeons will not be able to do
this procedure.
I believe that the criteria adopted by the Carotid Re-
vascularization and Endarterectomy vs Stent Trial
(CREST) Interventional Management Committee are a
reasonable starting point for credentialing committees.
These criteria have been vetted and corroborated by the
excellent results of the CREST lead-in phase.8 It is inter-
esting that there are no specific diagnostic cerebral angiog-
raphy requirements (Personal communication [oral], Dr
Gary Roubin, Chairman, CREST Interventional Commit-
tee, May 17, 2004). Previous percutaneous interventional
expertise is required as a starting point, and hospital proce-
dure notes and discharge summaries for 30 consecutive
patients undergoing carotid stenting must be submitted.
Those eligible would be interventionalists with percutane-
ous expertise, defined as someone with experience in guid-
ing catheters, self-expandable stents, 0.014-inch wire sys-
tems, and rapid exchange devices. The CREST experience
demonstrates that cardiologists and vascular surgeons with
expertise in percutaneous peripheral interventions can learn
carotid stenting and angioplasty, and do it well. This is a set
of guidelines that all credentialing bodies should follow,
because it is the only one that has been validated with
outcomes.
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Vascular surgeons, despite their minority status, per-
form one third of the endovascular procedures in the
United States. If one looks at device industry estimates for
2004 and considers which of the areas represent opportu-
nities for continued growth on the basis of improved tech-
nology and increased numbers of capable physicians, the 3
markets in which experts predict the greatest growth are
aortic aneurysm treatment, superior femoral artery recana-
lization, and carotid artery stenting (Fig 2). Internal indus-
try data clearly document that once a vascular surgeon
develops comfort and expertise with percutaneous proce-
dures, on average the surgeon’s use of peripheral devices
exceeds that of both radiologists and cardiologists. How
else could fewer than 15% of practitioners perform 35% of
procedures?
Fig 2. Endovascular procedures in the United States
abdominal aortic aneurysm (AAA), femoropopliteal (F
which vascular surgeons have established strong referral
Fig 3. Device industry data reflecting a survey performed
surgeons (VS), interventional cardiologists (IC), and inte
the question about providing follow-up care. Vascular su
80% of those questioned providing a high level of afterc
and interventional radiologists.Why, then, can’t we sell our specialty? If endocompe-
tent, we are the only providers who can offer patients a
variety of treatment options. We currently have dominant
positions in the three areas with the largest growth poten-
tial over the next generation. We have established referral
networks, and we have credibility as physicians.
In 2003 a device company commissioned a survey to
look at endovascular competence in 3 groups of physicians:
vascular surgeons, interventional radiologists, and inter-
ventional cardiologists. As expected, the range of expertise
varied among the groups, but the most striking difference
was in the response to the question about patient surveil-
lance after the procedure, where vascular surgeons were
clearly superior (Fig 3). If we have any claim for legitimacy
it is because of our commitment to the patient before,
during, and after an intervention.
ustry data). Areas of greatest anticipated growth are
op), and carotid interventions. These represent areas in
orks. VCF, Vena cava filters.
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We must recognize and accept that we are not the
controlling majority of those who treat vascular disease or
govern surgery. Rather than pretend otherwise, we must
take advantage of our limited resources and opportunities
without delay. All we need, with all of our talents, is a chance:
a chance to define our own training as we think best, and a
chance to continue to care for a segment of patients we
understand better than any other group. Let’s grab them,
because a live dog is indeed better than a dead lion.
Of course, not any dog will do. We cannot assume the
couch position and simmer in our ennui, waiting for our
master to come home from work. We must assume the
feisty attitude of the terrier, not the biggest, not the stron-
gest, but the most determined. We owe nothing less to our
patients and our heritage.
As for me, I know that King Solomon did not spend all
of his time ruminating about dead lions. As I leave this
podium in my penultimate act as president of the SVS and
return to New York, I plan on following another edict in
Ecclesiastes: “There is nothing better for mortals than to
eat and drink and find enjoyment in their work.”
Thank you for your support and for the opportunity
and honor to serve as your president. Good luck.REFERENCES
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